European Leukemia Trial Registry
Trial: APOLLO-TRIAL

More Details
Title Phase III Studie zu Arsentrioxid/ATRA/Idarubicin versus AIDA bei neu diagnostizierter Hochrisiko-APL
Short Title APOLLO-TRIAL
Trialgroup SAL
Type of Trial multicentric, randomized, open-label, double-group
Disease Acute myeloid leukemia(AML) FAB M3 (APL)
Age <= 65 years
Status Active
Start of Recruitment 01.01.2016
Leader Platzbecker, Prof. Dr. med., Uwe
Contactperson

Administrative needs
Sauer, Michaela
Tel: +49 (0)351 458 3192
Fax: +49 (0)351 458 43676
Email: michaela.sauer@uniklinikum-dresden.de

Shortprotocol Shortprotocol
created 11.10.2016 Student Studienregister
changed 18.10.2016 Student Studienregister
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org